- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/02 - 1,2-OxazinesHydrogenated 1,2-oxazines
Patent holdings for IPC class C07D 265/02
Total number of patents in this class: 44
10-year publication summary
|
4
|
1
|
2
|
4
|
2
|
4
|
2
|
4
|
5
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Schering Pharma AG | 422 |
6 |
| Chugai Seiyaku Kabushiki Kaisha | 1316 |
5 |
| BioMarin Pharmaceutical Inc. | 369 |
4 |
| Syngenta Crop Protection AG | 5744 |
3 |
| Novartis AG | 11063 |
2 |
| F. Hoffmann-La Roche AG | 7884 |
1 |
| Abbott Laboratories | 2435 |
1 |
| Japan Science and Technology Agency | 1383 |
1 |
| Adeka Corporation | 1350 |
1 |
| Chlorion Pharma, Inc. | 3 |
1 |
| Enanta Pharmaceuticals, Inc. | 430 |
1 |
| FMC Corporation | 843 |
1 |
| Howard University | 188 |
1 |
| Ishihara Sangyo Kaisha, Ltd. | 656 |
1 |
| Kyowa Hakko Kirin Co., Ltd. | 284 |
1 |
| Mintz Levin Cohn Ferris Glovsky and Popeo PC | 11 |
1 |
| Nanjing Cavendish Bio-Engineering Technology Co., Ltd. | 15 |
1 |
| Nihon Nohyaku Co., Ltd. | 315 |
1 |
| Paratek Pharmaceuticals, Inc. | 108 |
1 |
| Promega Corporation | 560 |
1 |
| Other owners | 9 |